Palvella Therapeutics, Inc.

Siren, L.L.C. PVLA
Report date
6/30/2026
Quarter
2026 Q2
Filed
8/13/2026
Shares
257,485
Value ($000)
39,349
Weight
0.8%
2025 Q4 - 2026 Q2 (3 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).